GlaxoSmithKline RSV vaccine (investigational name not provided in snippet)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GlaxoSmithKline RSV vaccine (investigational name not provided in snippet), covering 2026-06-23 to 2026-06-23. Get the full timeline:
Most recent: Clinical Trial Results: A Study in India on the Immune Response and Safety of a Respiratory Syncytial Virus (RSV) Older Adults (OA) Vaccine When Given to Older Adults 60 Years of Age and Above and Adults 50-59 Years of Age at Increased Risk (AIR) of Respiratory Syncytial Virus Lower Respiratory Tract Disease (RSV-LRTD) [Phase 3]